BRIDGEWAY CAPITAL MANAGEMENT, LLC - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 96 filers reported holding NEWLINK GENETICS CORP in Q3 2018. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q4 2019$274,000
+207.9%
108,400
+93.9%
0.00%
+300.0%
Q3 2019$89,000
-63.7%
55,900
-45.6%
0.00%
-50.0%
Q3 2018$245,000
-49.9%
102,7000.0%0.00%
-60.0%
Q2 2018$489,000
-34.4%
102,7000.0%0.01%
-37.5%
Q1 2018$745,000
-8.1%
102,700
+2.7%
0.01%
-11.1%
Q4 2017$811,000
-20.3%
100,0000.0%0.01%
-25.0%
Q3 2017$1,018,000100,0000.01%
Other shareholders
NEWLINK GENETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
NORTHWEST WEALTH MANAGEMENT, LLC 54,282$553,0000.77%
Redmile Group, LLC 1,248,700$12,712,0000.63%
FT Options LLC 20,796$212,0000.32%
Perceptive Advisors 900,000$9,162,0000.18%
Rhenman & Partners Asset Management AB 100,000$1,018,0000.13%
PDT Partners, LLC 349,981$3,563,0000.12%
Alambic Investment Management, L.P. 105,370$1,073,0000.12%
Endurant Capital Management LP 36,100$367,0000.11%
GSA CAPITAL PARTNERS LLP 132,154$1,345,0000.09%
COLUMBUS CIRCLE INVESTORS 485,848$4,946,0000.08%
View complete list of NEWLINK GENETICS CORP shareholders